
Please try another search
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Hans T. Schambye | 57 | 2020 | Co-Founder, President, CEO & Director |
Carl S. Goldfischer | 65 | 2020 | Independent Chairman of the Board |
Jayson Donald Alexander Dallas | 56 | 2020 | Independent Director |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Aaron Gerds | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Claire Harrison | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
David Shapiro | 70 | 2020 | Independent Director |
Jasmohan Bajaj | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
William L. Redmond | - | - | Member of Clinical Advisory Board – Oncology |
Adam Mead | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Raajit K. Rampal | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Jonathan Fallowfield | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
Anne Prener | 66 | 2021 | Independent Director |
Massimo Pinzani | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Mark Thursz | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Amit D. Munshi | 56 | 2020 | Independent Director |
Roy Steven Herbst | 61 | - | Member of Clinical Advisory Board – Oncology |
John Mascarenhas | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Federico Cappuzzo | - | - | Member of Clinical Advisory Board – Oncology |
Alexander Maximiliaan Marie Eggermont | - | - | Member of the Clinical Advisory Board – Oncology |
Amy B. Wechsler | 55 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review